EditorialsThe risks of androgen treatment in postmenopausal women remain controversial a need for equitable comparisonsPru, James K. PhD Author Information Vincent Center for Reproductive Biology Vincent Obstetrics and Gynecology Service Massachusetts General Hospital Boston, Massachusetts Financial disclosure: None reported. Menopause 16(3):p 430-431, May 2009. | DOI: 10.1097/gme.0b013e3181a057ef Buy Metrics ©2009The North American Menopause Society
